What is the recommended approach for pediatric Rapid Sequence Intubation (RSI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Rapid Sequence Intubation

Medication Regimen Overview

For pediatric RSI, administer atropine pretreatment (for children 28 days to 8 years), followed by ketamine as the first-line induction agent (1-2 mg/kg IV), and succinylcholine as the first-line neuromuscular blocker (age-adjusted dosing), with rocuronium (0.9-1.2 mg/kg IV) reserved for when succinylcholine is contraindicated. 1, 2


Step 1: Pretreatment with Atropine

Atropine is mandatory for children aged 28 days to 8 years to prevent bradycardia during laryngoscopy and from succinylcholine administration. 1, 2

  • Dosing: 0.01-0.02 mg/kg IV (maximum 0.5 mg) 1, 2
  • Timing: Administer during induction and before intubation 1
  • Especially critical in: Children with septic shock, hypovolemia, or when succinylcholine will be used 1, 2

Common pitfall: Failure to administer atropine in young children increases the risk of clinically significant bradycardia, particularly with succinylcholine use. 1

Optional Pretreatment for Elevated ICP

  • Lidocaine 1-2 mg/kg IV may be considered 30 seconds to 5 minutes before airway instrumentation in patients with increased intracranial pressure, though evidence is low quality. 1, 2

Step 2: Induction Agent Selection

First-Line: Ketamine

Ketamine is the preferred first-line induction agent for pediatric RSI, especially in hemodynamically unstable patients. 1, 2

  • Dosing: 1-2 mg/kg IV 1, 2
  • Alternative dosing by age: 3-4 mg/kg before 18 months; 2 mg/kg after 18 months 2
  • Advantages: Maintains hemodynamic stability through sympathomimetic effects 1
  • Preferred scenarios: Hemodynamically unstable patients, respiratory compromise 1, 2

Caveat: In critically ill patients with depleted catecholamine stores, ketamine may paradoxically cause hypotension despite its sympathomimetic properties. 3

Alternative: Etomidate

Etomidate is an alternative first-line agent, particularly useful in patients with head injury. 1

  • Dosing: 0.2-0.4 mg/kg IV (maximum 20 mg) 1, 2
  • Advantages: Minimal hemodynamic effects, lowers intracranial pressure 1
  • Age consideration: First-choice in children over 2 years old, except in sepsis 2
  • Important contraindication: Pediatric guidelines explicitly recommend against etomidate in septic shock due to adrenal suppression concerns. 3

Step 3: Neuromuscular Blocking Agent Selection

First-Line: Succinylcholine

Succinylcholine is the first-line neuromuscular blocker for pediatric RSI in patients with respiratory or cardiovascular compromise. 4, 1, 2

Age-Adjusted Dosing:

  • >10 years: 1-1.5 mg/kg IV 1, 2
  • 1-10 years: 1.2 mg/kg IV 4, 1, 2
  • 1 month to 1 year: 2.0 mg/kg IV 4, 1, 2
  • <1 month (neonates): 1.8 mg/kg IV 1, 2

Rationale: Succinylcholine provides rapid onset and short duration, making it ideal for RSI when no contraindications exist. 4

Critical pitfall: Using succinylcholine in patients with contraindications such as hyperkalemia can lead to cardiac arrest. 1

Alternative: Rocuronium

Rocuronium should be used when succinylcholine is contraindicated. 4, 1, 2

  • Dosing: 0.9-1.2 mg/kg IV (doses >0.9 mg/kg recommended) 4, 1, 2, 5
  • Onset: Provides excellent intubating conditions within 60-75 seconds at appropriate doses 5
  • Duration consideration: Longer duration of action than succinylcholine must be weighed against succinylcholine's side effect risks 4

Essential safety measure: Sugammadex must be rapidly available when rocuronium is used for potential reversal in a "can't intubate, can't ventilate" scenario. 4, 1, 2

Important note: Rocuronium is NOT recommended for rapid sequence intubation in pediatric patients according to FDA labeling, though clinical guidelines support its use as an alternative to succinylcholine. 5


Step 4: Equipment and Monitoring Requirements

  • Personnel with airway management skills must be present when neuromuscular blockers are administered 2
  • Age-appropriate equipment for aspiration, oxygenation, intubation, and ventilation must be immediately available 2
  • Continuous oxygen saturation monitoring is required 2
  • Peripheral nerve stimulator should be available to confirm adequate blockade before intubation attempt 3

Step 5: Videolaryngoscopy Consideration

Videolaryngoscopy should be used as first option for patients with anticipated difficult intubation but possible mask ventilation, or after failure of direct laryngoscopy. 4

  • Videolaryngoscopy improves glottic vision and increases first-attempt success rates in children with difficult airway criteria 4
  • External laryngeal maneuvers are facilitated when using videolaryngoscopy with a remote screen 4

Clinical Outcomes and Success Rates

  • RSI demonstrates superior first-attempt success (78%) compared to intubation without medications (47%) or sedation alone (44%) in pediatric emergency department patients 6
  • Overall success rate with RSI: 99% in pediatric emergency intubations 6
  • Complication rate with RSI: Only 1% true complications in pediatric emergency department RSI 6
  • Ketamine-only approach (without paralytic) is NOT recommended: Associated with only 61% first-attempt success and 32% adverse event rate, significantly worse than standard RSI 7

Common Pitfalls to Avoid

  1. Omitting atropine in young children (28 days to 8 years), particularly when using succinylcholine 1, 2
  2. Using succinylcholine in patients with hyperkalemia risk (burns, crush injuries, neuromuscular disease) 1
  3. Failing to have sugammadex immediately available when using high-dose rocuronium 1, 2
  4. Using etomidate in septic patients due to adrenal suppression concerns 3, 2
  5. Attempting intubation before full neuromuscular blockade is achieved (wait at least 60 seconds after rocuronium) 3

References

Guideline

Pediatric Rapid Sequence Intubation Medication Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Intubation in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Intubation Medication Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.